BlackRock Fund Advisors’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$10.4M	Buy	438,231 +54,463	+14%	+$1.56M	﹤0.01%	2549
2016 Q3	$14.1M	Buy	383,768 +26,195	+7%	+$751K	﹤0.01%	2261
2016 Q2	$7.97M	Buy	357,573 +14,787	+4%	+$368K	﹤0.01%	2535
2016 Q1	$7.13M	Buy	342,786 +5,213	+2%	+$129K	﹤0.01%	2552
2015 Q4	$10.2M	Buy	337,573 +109,991	+48%	+$3.33M	﹤0.01%	2429
2015 Q3	$5.62M	Sell	227,582 -2,643	-1%	-$78.9K	﹤0.01%	2732
2015 Q2	$7.39M	Sell	230,225 -7,037	-3%	-$269K	﹤0.01%	2680
2015 Q1	$8.47M	Sell	237,262 -3,057	-1%	-$83.8K	﹤0.01%	2529
2014 Q4	$5.46M	Sell	240,319 -76,629	-24%	-$1.55M	﹤0.01%	2826
2014 Q3	$6.15M	Sell	316,948 -8,801	-3%	-$249K	﹤0.01%	2622
2014 Q2	$11.8M	Sell	325,749 -24,448	-7%	-$831K	﹤0.01%	2318
2014 Q1	$13.6M	Buy	350,197 +8,392	+2%	+$299K	﹤0.01%	2220
2013 Q4	$9.74M	Sell	341,805 -75,534	-18%	-$2.22M	﹤0.01%	2409
2013 Q3	$14.9M	Buy	417,339 +31,991	+8%	+$1.17M	0.01%	2120
2013 Q2	$12.9M	Buy	+385,348	New	+$17.5M	﹤0.01%	2117